Prospective assessment of estrogen replacement therapy and cognitive functioning

Atherosclerosis Risk in Communities Study

Suzana Alves De Moraes, Moyses Szklo, David Knopman, Eunsik Park

Research output: Contribution to journalArticle

Abstract

Studies of humans have not confirmed the suggestion from animal studies that estrogen replacement therapy may have an inverse relation with cognitive function decline. Because many of these studies have been marred by design or methodological problems, such as a small sample size, failure to control for confounding variables, or the use of a cross-sectional design, the present study was conducted in a large cohort of middle-aged postmenopausal women participating in the Atherosclerosis Risk in Communities (ARIC) Study. The study population consisted of 2,859 women aged 48-67 years, whose cognitive function was tested at the second (1990-1992) and fourth (1996-1998) visits of the ARIC Study using three instruments: the Delayed Word Recall Test, Digit Symbol Subtest of the Wechsler Adult Intelligence Scale-Revised, and Word Fluency Test. After multiple adjustment, no consistent patterns of cognitive changes between the two cohort visits could be detected according to current use or duration of use of estrogen replacement therapy. Thus, the results of the present study do not support the hypothesis that estrogen replacement therapy may slow age-related cognitive decline, at least as it applies to relatively young postmenopausal women.

Original languageEnglish (US)
Pages (from-to)733-739
Number of pages7
JournalAmerican Journal of Epidemiology
Volume154
Issue number8
DOIs
StatePublished - Oct 15 2001

Fingerprint

Estrogen Replacement Therapy
Atherosclerosis
Cognition
Social Adjustment
Confounding Factors (Epidemiology)
Intelligence
Sample Size
Population
Cognitive Dysfunction

Keywords

  • Cognition disorders
  • Cohort studies
  • Estrogen replacement therapy
  • Menopause
  • Women's health

ASJC Scopus subject areas

  • Epidemiology

Cite this

Prospective assessment of estrogen replacement therapy and cognitive functioning : Atherosclerosis Risk in Communities Study. / Alves De Moraes, Suzana; Szklo, Moyses; Knopman, David; Park, Eunsik.

In: American Journal of Epidemiology, Vol. 154, No. 8, 15.10.2001, p. 733-739.

Research output: Contribution to journalArticle

@article{3712913221b04bf3a448444e8ad1ef28,
title = "Prospective assessment of estrogen replacement therapy and cognitive functioning: Atherosclerosis Risk in Communities Study",
abstract = "Studies of humans have not confirmed the suggestion from animal studies that estrogen replacement therapy may have an inverse relation with cognitive function decline. Because many of these studies have been marred by design or methodological problems, such as a small sample size, failure to control for confounding variables, or the use of a cross-sectional design, the present study was conducted in a large cohort of middle-aged postmenopausal women participating in the Atherosclerosis Risk in Communities (ARIC) Study. The study population consisted of 2,859 women aged 48-67 years, whose cognitive function was tested at the second (1990-1992) and fourth (1996-1998) visits of the ARIC Study using three instruments: the Delayed Word Recall Test, Digit Symbol Subtest of the Wechsler Adult Intelligence Scale-Revised, and Word Fluency Test. After multiple adjustment, no consistent patterns of cognitive changes between the two cohort visits could be detected according to current use or duration of use of estrogen replacement therapy. Thus, the results of the present study do not support the hypothesis that estrogen replacement therapy may slow age-related cognitive decline, at least as it applies to relatively young postmenopausal women.",
keywords = "Cognition disorders, Cohort studies, Estrogen replacement therapy, Menopause, Women's health",
author = "{Alves De Moraes}, Suzana and Moyses Szklo and David Knopman and Eunsik Park",
year = "2001",
month = "10",
day = "15",
doi = "10.1093/aje/154.8.733",
language = "English (US)",
volume = "154",
pages = "733--739",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Prospective assessment of estrogen replacement therapy and cognitive functioning

T2 - Atherosclerosis Risk in Communities Study

AU - Alves De Moraes, Suzana

AU - Szklo, Moyses

AU - Knopman, David

AU - Park, Eunsik

PY - 2001/10/15

Y1 - 2001/10/15

N2 - Studies of humans have not confirmed the suggestion from animal studies that estrogen replacement therapy may have an inverse relation with cognitive function decline. Because many of these studies have been marred by design or methodological problems, such as a small sample size, failure to control for confounding variables, or the use of a cross-sectional design, the present study was conducted in a large cohort of middle-aged postmenopausal women participating in the Atherosclerosis Risk in Communities (ARIC) Study. The study population consisted of 2,859 women aged 48-67 years, whose cognitive function was tested at the second (1990-1992) and fourth (1996-1998) visits of the ARIC Study using three instruments: the Delayed Word Recall Test, Digit Symbol Subtest of the Wechsler Adult Intelligence Scale-Revised, and Word Fluency Test. After multiple adjustment, no consistent patterns of cognitive changes between the two cohort visits could be detected according to current use or duration of use of estrogen replacement therapy. Thus, the results of the present study do not support the hypothesis that estrogen replacement therapy may slow age-related cognitive decline, at least as it applies to relatively young postmenopausal women.

AB - Studies of humans have not confirmed the suggestion from animal studies that estrogen replacement therapy may have an inverse relation with cognitive function decline. Because many of these studies have been marred by design or methodological problems, such as a small sample size, failure to control for confounding variables, or the use of a cross-sectional design, the present study was conducted in a large cohort of middle-aged postmenopausal women participating in the Atherosclerosis Risk in Communities (ARIC) Study. The study population consisted of 2,859 women aged 48-67 years, whose cognitive function was tested at the second (1990-1992) and fourth (1996-1998) visits of the ARIC Study using three instruments: the Delayed Word Recall Test, Digit Symbol Subtest of the Wechsler Adult Intelligence Scale-Revised, and Word Fluency Test. After multiple adjustment, no consistent patterns of cognitive changes between the two cohort visits could be detected according to current use or duration of use of estrogen replacement therapy. Thus, the results of the present study do not support the hypothesis that estrogen replacement therapy may slow age-related cognitive decline, at least as it applies to relatively young postmenopausal women.

KW - Cognition disorders

KW - Cohort studies

KW - Estrogen replacement therapy

KW - Menopause

KW - Women's health

UR - http://www.scopus.com/inward/record.url?scp=0035887897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035887897&partnerID=8YFLogxK

U2 - 10.1093/aje/154.8.733

DO - 10.1093/aje/154.8.733

M3 - Article

VL - 154

SP - 733

EP - 739

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 8

ER -